Metformin Disappoints in Two Phase 2 Lung Cancer Trials ...Middle East

Medscape - News
Although well tolerated, metformin did not improve survival when given alongside chemoradiotherapy to patients with locally advanced non-small cell lung cancer (NSCLC). Medscape Medical News

Hence then, the article about metformin disappoints in two phase 2 lung cancer trials was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Metformin Disappoints in Two Phase 2 Lung Cancer Trials )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News